LightPath Technologies Reports Second Quarter Fiscal 2025 Financial Results

ORLANDO, Fla., Feb. 13, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal 2025 second quarter ended December 31, 2024.

Financial Summary:


                                             Three Months Ended December
                                                  31,


        
        
              $ in millions   2024           2023               % Change



     
       Revenue                       $7.4           $7.3                  1.5 %



     
       Gross Profit                  $1.9           $2.2                -11.0 %



     
       Operating Expenses            $4.4           $4.0                 11.7 %



     
       Net Income (Loss)           ($2.6)        ($1.7)                52.4 %



     
       EBITDA* (non-GAAP)          ($1.5)        ($0.5)               228.9 %

Second Quarter Fiscal 2025 & Subsequent Highlights:

    --  Announced the acquisition of G5 Infrared ("G5"), a leading high-end
        infrared camera systems manufacturer, part of LightPath's strategic
        vision to become a leading vertically integrated infrared ("IR") imaging
        solutions provider, and financing related to the transaction
    --  Began sustained delivery of infrared assemblies to a European defense
        customer for active-duty use in First-Person View ("FPV") drone
        applications
    --  Launched new optical gas imaging ("OGI") cameras, including:
        --  OGI cameras for ammonia and sulfur hexafluoride ("SF6") detection at
            industrial and manufacturing facilities
        --  OGI cameras for detecting fugitive gas emissions for Oil & Gas
            applications, launched at the CH4 Connections Conference
    --  Awarded Phase 2 funding in U.S. Defense Department partnership to
        qualify additional BlackDiamond glasses as germanium substitutes
    --  Participated in leading investor conferences including the LD Micro Main
        Event, the 27(th) Annual Needham Growth Conference and the Sequire
        Investor Summit Puerto Rico

Management Commentary

Sam Rubin, President and Chief Executive Officer of LightPath, said: "The second quarter of fiscal 2025 was highlighted by the acquisition of G5 Infrared, marking a significant step forward as part of our evolution towards becoming a leading vertically integrated, global solutions provider for infrared imaging technologies for defense and commercial applications. G5 achieved preliminary unaudited calendar year 2024 revenues of more than $15 million and we believe there is significant room for near-term growth on the back of multiple programs of record and that we will benefit from G5's higher-average selling price ("ASP") and high-margin cooled infrared camera offering.

"G5 provides a highly incremental offering to LightPath, providing a broad range of cooled infrared camera solutions and assemblies, ranging from high performance mid wave zoom thermal imaging camera systems to thin film deposition services on a variety of infrared substrates, all of which are complimentary to our line of uncooled infrared cameras, infrared optics and infrared materials. The company has a significant pipeline of new business opportunities, with multiple program awards expected to begin production in the next two years. We believe that this will drive a robust growth profile and margins that will aid us as we pursue our long-term goal of 15% EBITDA margins at the corporate level. We expect to add significant value beyond the immediately accretive revenue stream and believe the acquisition will continue to drive future growth with its higher ASPs, incremental products and notable operational synergies - such as integrating their offerings with our proprietary BlackDiamond(TM) glass and in-house optics manufacturing capabilities.

"In the European market, during the quarter we received an initial development contract from a new European defense customer for the use of BlackDiamond glass in optical systems. We also began sustained delivery of infrared lens assemblies per the terms of the October 2024 Letter of Intent from a European defense customer for active duty use in FPV drone applications. This order highlights two exciting opportunities for LightPath, making the most of our European Defense license acquired last year, which positions us to supply products to one of the largest defense markets in the world. The order also highlights the growing use of drones and unmanned aerial vehicles for a variety of defense applications, giving our proprietary BlackDiamond(TM) chalcogenide-based glass materials an opportunity to become an important material for thermal cameras in these vehicles.

"We continued to expand our product portfolio and market potential with the launch of our OGI camera platform, a specialized technology utilizing IR cameras to detect and visualize emissions. Our first variation for oil and gas applications is useful for detecting methane, volatile organic compounds, hydrocarbons, and other industrial gases that can be harmful to the environment or human health. A second version was launched to detect fugitive ammonia and SF6 emissions for industrial and manufacturing applications. Not only are these cameras cost effective, highly sensitive, and operational without proprietary software, but they are also built with a non-germanium lens. This feature is becoming increasingly important to customers looking for insulation from the geopolitical supply chain issues plaguing competing Germanium based solutions - such as China's recent ban on the export of Germanium to the United States. On December 4, 2024, China announced further restrictions on export of Germanium to the U.S. altogether, as well as for dual-use applications in other countries as well. LightPath has been preparing for this day with the introduction of our BlackDiamond materials, qualification of those materials through our partnership with the U.S. Department of Defense - Defense Logistics Agency, and working with customers to redesign their systems to replace Germanium optics. Since China's announcement we have seen a growing interest and demand in our BlackDiamond materials and are encouraged to see customers begin the process to switch over to those materials.

"As we move into calendar year 2025, we look forward to integrating G5 into the LightPath family and benefiting from its strong pipeline of new business opportunities in the government and defense sectors. We also expect to move forward with key defense programs, including our bid to produce a design of a major missile program for the U.S. Army with Lockheed Martin. We are now starting to deliver flightworthy hardware for implementation into Lockheed Martin's initial live test units for this program, from which we believe the U.S. Army could make a decision as early as later this year. Taken together, we believe 2025 will build additional momentum toward our vision of becoming a vertically integrated, next-generation optics and imaging solutions provider," concluded Rubin.

Second Quarter Fiscal 2025 Financial Results

Revenue for the second quarter of fiscal 2025 increased 1.5% to $7.4 million, as compared to $7.3 million in the same quarter of the prior fiscal year. Revenue was split amongst the Company's product groups in the second quarter of fiscal 2025 as follows:


                         Product Group Revenue           Second Quarter
                                                                of               Second Quarter of  % Change
               ($ in millions)**               Fiscal 2025              Fiscal 2024



     Infrared ("IR") Components                                   $3.1                        $3.6      -13 %



     Visible Components                                           $2.8                        $2.7        3 %



     Assemblies & Modules                                         $0.9                        $1.0      -13 %



     Engineering Services                                         $0.7                        $0.1      797 %

** Numbers may not foot due to rounding

Gross profit decreased 11% to $1.9 million, or 26% of total revenues, in the second quarter of 2025, as compared to $2.2 million, or 30% of total revenues, in the same quarter of the prior fiscal year. The decrease in gross margin as a percentage of revenue is primarily due to differences in the product mix, coupled with some manufacturing yield issues in infrared components.

Operating expenses increased 12% to $4.4 million for the second quarter of fiscal 2025, as compared to $4.0 million in the same quarter of the prior fiscal year. The increase was primarily due to higher legal and consulting fees related to business development initiatives, including expenses associated with the G5 acquisition announced today, as well as increased sales and marketing spend to promote new products and an increase in materials spend for internally funded new product development projects.

Net loss in the second quarter of fiscal 2025 totaled $2.6 million, or $0.07 per basic and diluted share, as compared to $1.7 million, or $0.05 per basic and diluted share, in the same quarter of the prior fiscal year. The increase in net loss was primarily attributable to lower gross profit coupled with increased SG&A and new product development costs, as well as higher interest expense.

EBITDA* loss for the second quarter of fiscal 2025 was $1.5 million, compared to a loss of $0.5 million for the same period of the prior fiscal year. The decrease in EBITDA in the second quarter of fiscal 2025 was primarily attributable to lower gross profit coupled with increased SG&A, including legal and consulting expenses related to business development initiatives, and new product development costs.

G5 Acquisition & Second Quarter Fiscal 2025 Earnings Call

Management will host an investor conference call at 5:00 p.m. Eastern time today, Thursday, February 13, 2025, to discuss the Company's second quarter fiscal 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Date: Thursday, February 13, 2025
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13749940
Webcast: LPTH Q2 FY2025 Earnings Conference Call

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Thursday, February 27, 2025. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 13749940. A webcast replay will also be available using the webcast link above.

About LightPath Technologies

LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath's family of custom solutions range from proprietary BlackDiamond(TM) chalcogenide-based glass materials - sold under exclusive license from the U.S. Naval Research Laboratory - to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, Latvia and China. To learn more, please visit www.lightpath.com.

*Use of Non-GAAP Financial Measures

To provide investors with additional information regarding financial results, this press release includes references to EBITDA, which is a non-GAAP financial measure. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization.

A "non-GAAP financial measure" is generally defined as a numerical measure of a company's historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company's management believes that this non-GAAP financial measure, when considered together with the GAAP financial measure, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that this non-GAAP financial measure enhances the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.


                                              
              
                LIGHTPATH TECHNOLOGIES, INC.


                                   
     
              Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure




                                                                                                
              
                (unaudited)


                                                                            Three Months Ended December 31,                                   Three Months Ended December 31,


                                                                    2024                                    2023                            2024                                   2023



              Net loss                $(2,611,997)                          $(1,713,663)                           $(4,234,742)                   $(3,056,039)



              Depreciation and             904,040                              1,129,444                               1,893,602                       1,943,000
    amortization


               Income tax provision          44,525                                 76,058                                  60,161                         115,604



              Interest expense             169,053                                 53,788                                 318,413                         111,399


                                       EBITDA                 $(1,494,379)                             $(454,373)                   $(1,962,566)                            $(886,036)


                                       % of revenue                  -20 %                                   -6 %                          -12 %                                  -6 %

Forward-Looking Statements

This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements are based on information available at the time the statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the impact of varying demand for the Company products; the ability of the Company to obtain needed raw materials and components from its suppliers; actions governments, businesses, and individuals take in response to the pandemic, including restrictions on onsite commercial interactions; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions, the Russian-Ukraine conflict, and the Hamas/ Israel war; the effects of steps that the Company could take to reduce operating costs; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; and those factors detailed by LightPath Technologies, Inc. in its public filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on 10-Q. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.


                                                                                      
              
                LIGHTPATH TECHNOLOGIES, INC.


                                                                                  
              
                Condensed Consolidated Balance Sheets


                                                                                               
              
                (unaudited)


                                                                                                                                                              December 31,                    June 30,


                                                                     
              
                Assets                                                        2024                      2024



              Current assets:



              Cash and cash equivalents                                                                                                         $
         3,201,066           $
          3,480,268



              Trade accounts receivable, net of allowance of $20,172 and $25,676                                                                       5,279,634                   4,928,931



              Inventories, net                                                                                                                         6,428,439                   6,551,059



              Prepaid expenses and deposits                                                                                                              649,270                     445,900



              Other current assets                                                                                                                        89,891                     131,177



              Total current assets                                                                                                                    15,648,300                  15,537,335





              Property and equipment, net                                                                                                             14,054,829                  15,210,612



              Operating lease right-of-use assets                                                                                                      6,218,147                   6,741,549



              Intangible assets, net                                                                                                                   2,960,252                   3,650,739



              Goodwill                                                                                                                                 6,764,127                   6,764,127



              Deferred tax assets, net                                                                                                                   123,000                     123,000



              Other assets                                                                                                                                59,536                      59,602



              Total assets                                                                                                                     $
         45,828,191          $
          48,086,964


                                                      
              
                Liabilities and Stockholders' Equity



              Current liabilities:



              Accounts payable                                                                                                                  $
         3,114,382           $
          3,231,713



              Accrued liabilities                                                                                                                      1,448,584                   1,911,867



              Accrued payroll and benefits                                                                                                             1,445,924                   1,446,452



              Operating lease liabilities, current                                                                                                       997,957                   1,059,998



              Loans payable, current portion                                                                                                           3,017,443                     209,170



              Finance lease obligation, current portion                                                                                                  203,739                     177,148



              Total current liabilities                                                                                                               10,228,029                   8,036,348





              Deferred tax liabilities, net                                                                                                              323,402                     326,197



              Accrued liabilities, noncurrent                                                                                                            315,480                     611,619



              Finance lease obligation, less current portion                                                                                             496,025                     528,753



              Operating lease liabilities, noncurrent                                                                                                  7,539,488                   8,058,502



              Loans payable, less current portion                                                                                                        222,829                     325,880



              Total liabilities                                                                                                                       19,125,253                  17,887,299





              Commitments and Contingencies





              Stockholders' equity:



              Preferred stock: Series D, $.01 par value, voting; 500,000 shares authorized;
    none issued and outstanding



              Common stock: Class A, $.01 par value, voting; 94,500,000 shares                                                                           398,908                     392,546
    authorized; 39,890,834 and 39,254,643 shares issued and outstanding



              Additional paid-in capital                                                                                                             246,051,852                 245,140,758



              Accumulated other comprehensive income                                                                                                     330,495                     509,936



              Accumulated deficit                                                                                                                  (220,078,317)              (215,843,575)



              Total stockholders' equity                                                                                                              26,702,938                  30,199,665



              Total liabilities and stockholders' equity                                                                                       $
         45,828,191          $
          48,086,964


                                                                 
          
                LIGHTPATH TECHNOLOGIES, INC.


                                                             
     
       Condensed Consolidated Statements of Comprehensive Income (Loss)


                                                                     
              
                (unaudited)




                                                                                                               Three Months Ended                              Six Months Ended


                                                                                                                  December 31,                                   December 31,


                                                                                                     2024                               2023                2024                         2023



             Revenue, net                                                            $
              7,424,829                   $
           7,315,637    $
          15,825,210             $
          15,392,885



             Cost of sales                                                                       5,493,998                            5,147,316            11,049,950                     10,892,858



             Gross profit                                                                        1,930,831                            2,168,321             4,775,260                      4,500,027



             Operating expenses:



             Selling, general and administrative                                                 3,356,063                            2,858,457             6,626,646                      5,519,625



             New product development                                                               764,396                              607,747             1,240,837                      1,247,636



             Amortization of intangible assets                                                     294,711                              485,446               690,487                        766,717



             Loss on disposal of property and equipment                                                                                                      78,437



             Total operating expenses                                                            4,415,170                            3,951,650             8,636,407                      7,533,978



             Operating loss                                                                    (2,484,339)                         (1,783,329)          (3,861,147)                   (3,033,951)



             Other income (expense):



             Interest expense, net                                                               (169,053)                            (53,788)            (318,413)                     (111,399)



             Other income, net                                                                      85,920                              199,512                 4,979                        204,915



             Total other expense, net                                                             (83,133)                             145,724             (313,434)                        93,516



             Loss before income taxes                                                          (2,567,472)                         (1,637,605)          (4,174,581)                   (2,940,435)



             Income tax provision                                                                   44,525                               76,058                60,161                        115,604



             Net loss                                                              $
              (2,611,997)                $
           (1,713,663)  $
          (4,234,742)            $
         (3,056,039)



             Foreign currency translation adjustment                                             (451,035)                             259,973             (179,441)                       134,765



             Comprehensive loss                                                    $
              (3,063,032)                $
           (1,453,690)  $
          (4,414,183)            $
         (2,921,274)



             Loss per common share (basic)                                              $
              (0.07)                     $
           (0.05)       $
          (0.11)                $
          (0.08)



             Number of shares used in per share calculation                                     39,728,933                           37,501,683            39,645,206                     37,466,714
    (basic)



             Loss per common share (diluted)                                            $
              (0.07)                     $
           (0.05)       $
          (0.11)                $
          (0.08)



             Number of shares used in per share calculation                                     39,728,933                           37,501,683            39,645,206                     37,466,714
    (diluted)


                                                                                  
             
                LIGHTPATH TECHNOLOGIES, INC.


                                                                        
     
              Condensed Consolidated Statements of Changes in Stockholders' Equity


                                                                                         
              
                (unaudited)


                                                                                                                                                                  Accumulated


                                                              Class A                                     Additional                                         Other                                                            Total


                                                           Common Stock                                    Paid-in                                       Comphrehensive                       Accumulated                  Stockholders'


                                                   Shares                           Amount                                         Capital                                          Income                       Deficit                        Equity


                            Balances at 39,254,643        $
              
       392,546               $
              
                245,140,758                  $
              
                509,936     $
           
           (215,843,575) $
              
           30,199,665
    June 30, 2024



              Issuance of
    common stock
    for:



              Employee                      8,232                             82                                             10,290                                                                                                             10,372
    Stock Purchase
    Plan



              Exercise of                  70,309                            703                                              (703)
    Stock Options,
    RSUs & RSAs,
    net



              Issuance of                 279,553                          2,796                                            318,562                                                                                                            321,358
    common stock
    for acquisition
    of Visimid



              Stock-based                                                                                                 264,475                                                                                                            264,475
    compensation
    on stock
    options, RSUs
    & RSAs



              Foreign                                                                                                                                                      271,594                                                           271,594
    currency
    translation
    adjustment



              Net loss                                                                                                                                                                                   (1,622,745)                    (1,622,745)


                            Balances at 39,612,737        $
              
       396,127               $
              
                245,733,382                  $
              
                781,530     $
           
           (217,466,320) $
              
           29,444,719
    September 30,
    2024



              Issuance of
    common stock
    for:



              Exercise of                 229,097                          2,291                                            (2,291)
    Stock Options,
    RSUs & RSAs,
    net


               Shares issued as             49,000                            490                                             89,180                                                                                                             89,670
    compensation



              Stock-based                                                                                                 231,581                                                                                                            231,581
    compensation
    on stock
    options, RSUs
    & RSAs



              Foreign                                                                                                                                                    (451,035)                                                        (451,035)
    currency
    translation
    adjustment



              Net loss                                                                                                                                                                                   (2,611,997)                    (2,611,997)


                            Balances at 39,890,834        $
              
       398,908               $
              
                246,051,852                  $
              
                330,495     $
           
           (220,078,317) $
              
           26,702,938
    December 31,
    2024




                            Balances at 37,344,739        $
              
       373,447               $
              
                242,808,771                  $
              
                606,536     $
           
           (207,836,229) $
              
           35,952,525
    June 30, 2023



              Issuance of
    common stock
    for:



              Employee                     14,607                            146                                             19,573                                                                                                             19,719
    Stock Purchase
    Plan



              Exercise of                  14,482                            145                                              (145)
    Stock Options,
    RSUs & RSAs,
    net



              Issuance of                  81,610                            816                                            149,184                                                                                                            150,000
    common stock
    for acquisition
    of Visimid



              Stock-based                                                                                                 240,075                                                                                                            240,075
    compensation
    on stock
    options, RSUs
    & RSAs



              Foreign                                                                                                                                                    (125,208)                                                        (125,208)
    currency
    translation
    adjustment



              Net loss                                                                                                                                                                                   (1,342,376)                    (1,342,376)


                            Balances at 37,455,438        $
              
       374,554               $
              
                243,217,458                  $
              
                481,328     $
           
           (209,178,605) $
              
           34,894,735
    September 30,
    2023



              Issuance of
    common stock
    for:



              Exercise of                  93,940                            940                                              (940)
    Stock Options,
    RSUs & RSAs,
    net



              Stock-based                                                                                                 258,691                                                                                                            258,691
    compensation
    on stock
    options, RSUs
    & RSAs



              Foreign                                                                                                                                                      259,973                                                           259,973
    currency
    translation
    adjustment



              Net loss                                                                                                                                                                                   (1,713,663)                    (1,713,663)


                            Balances at 37,549,378        $
              
       375,494               $
              
                243,475,209                  $
              
                741,301     $
           
           (210,892,268) $
              
           33,699,736
    December 31,
    2023


                                                                                     
             
              LIGHTPATH TECHNOLOGIES, INC.


                                                                            
              
             Condensed Consolidated Statements of Cash Flows


                                                                                             
            
                (unaudited)


                                                                                                                                                                         Six Months Ended
                                                                                                                                                               December 31,


                                                                                                                                                              2024                               2023



              Cash flows from operating activities:



              Net loss                                                                                                                          $
          (4,234,742)                $
           (3,056,039)



              Adjustments to reconcile net loss to net cash (used in) provided by operating
    activities:



              Depreciation and amortization                                                                                                               1,893,602                            1,943,000



              Interest from amortization of loan issuance costs                                                                                             120,833



              Loss on disposal of property and equipment                                                                                                     78,437



              Stock-based compensation on stock options, RSUs & RSAs, net                                                                                   506,020                              551,853



              Provision for credit losses                                                                                                                                                       (2,236)



              Change in operating lease assets and liabilities                                                                                             (57,653)                              80,355



              Inventory write-offs to allowance                                                                                                             135,625                               73,569



              Deferred taxes                                                                                                                                (2,795)                               9,395



              Changes in operating assets and liabilities:



              Trade accounts receivable                                                                                                                   (350,703)                           1,717,283



              Other current assets                                                                                                                           41,286                            (191,381)



              Inventories                                                                                                                                  (13,005)                              54,461



              Prepaid expenses and deposits                                                                                                               (123,598)                              94,619



              Accounts payable and accrued liabilities                                                                                                    (430,923)                           (424,310)



              Net cash (used in) provided by operating activities                                                                                       (2,437,616)                             850,569





              Cash flows from investing activities:



              Purchase of property and equipment                                                                                                          (160,155)                         (1,484,401)



              Proceeds from sale of equipment                                                                                                                10,648



              Proceeds from sale-leaseback of equipment                                                                                                                                         364,710



              Acquisition of Visimid, net of cash acquired                                                                                                                                    (722,141)



              Net cash used in investing activities                                                                                                       (149,507)                         (1,841,832)





              Cash flows from financing activities:



              Proceeds from sale of common stock from Employee Stock Purchase Plan                                                                           10,372                               19,719



              Deferred payment for acquisition of Visimid                                                                                                 (125,000)



              Loan issuance costs                                                                                                                         (300,000)



              Borrowings on loans payable                                                                                                                 3,000,000                              142,853



              Payments on loans payable                                                                                                                   (106,486)                           (407,510)



              Repayment of finance lease obligations                                                                                                       (89,705)                            (58,785)



              Net cash provided by (used in) financing activities                                                                                         2,389,181                            (303,723)



              Effect of exchange rate on cash and cash equivalents                                                                                         (81,260)                              32,698



              Change in cash, cash equivalents and restricted cash                                                                                        (279,202)                         (1,262,288)



              Cash, cash equivalents and restricted cash, beginning of period                                                                             3,480,268                            7,144,490



              Cash, cash equivalents and restricted cash, end of period                                                                           $
          3,201,066                   $
           5,882,202





              Supplemental disclosure of cash flow information:



              Interest paid in cash                                                                                                                  $
          40,838                     $
           110,774



              Income taxes paid                                                                                                                      $
          61,427                     $
           114,953



              Supplemental disclosure of non-cash investing & financing activities:



              Purchase of equipment through finance lease arrangements                                                                               $
          93,048                      $
           61,654



              Issuance of common stock for acquisition of Visimid                                                                                   $
          321,358                     $
           150,000

View original content to download multimedia:https://www.prnewswire.com/news-releases/lightpath-technologies-reports-second-quarter-fiscal-2025-financial-results-302375943.html

SOURCE LightPath Technologies